Main competitors
P/E (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Dividend Yield (Y) Capi.($)
-8.16x3.9x-0.2x3.49x-6.35x-5.99x-.--% 2.06B
18.4x2.08x-2.08x3.96x10.22x11.85x0.56% 70.75B
26.88x4.06x1.94x5.56x16.35x20.27x0.58% 54.35B
36.02x7.41x0.66x12.31x23.42x27.4x-.--% 47.19B
-47.07x2.64x0.36x3.33x9.85x11.49x3.21% 42.48B
30.86x1.91x-1.35x3.49x11.63x14.06x-.--% 30.91B
57.4x4.37x-0.88x3.57x25.12x24.64x-.--% 25.76B
-6.29x3.82x-0.32x8.71x-5.35x-5.01x-.--% 21.62B
64.77x5.82x0.42x6.36x43.76x49.37x-.--% 19.91B
-37.55x-6.66x0.91x17.86x-48.89x-56.5x-.--% 16.33B
24.82x3.65x0.02x5.32x13.85x19.25x-.--% 16.9B
-110.32x12045.55x2.51x11.84x-84.78x-118.16x-.--% 11.7B
18.17x - 0.21x3.71x14.35x16.76x-.--% 11.86B
51.69x21.08x0.49x31.22x44.15x45.53x0.18% 10.43B
48.64x - 5.3x - - - -.--% 10.71B
13.41x1.26x0.43x1.92x7.91x10.54x3.1% 7.09B
64.06x7.91x0.94x6.21x34.4x46.28x-.--% 6.31B
29.32x - 1.44x7.9x20.96x25.03x0.35% 5.99B
57.58x4.07x-0.74x - - - - 5.47B
-42.23x - -0.76x - - - - 5.32B
Average 14.52x 757.05x 0.47x 8.04x 7.68x 8.05x 0.44% 21.16B
Weighted average by Cap. 15.57x 365.89x 0.14x 7.01x 10.85x 12.11x 0.57%
Biopharmaceuticals